Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bird Rock Bio Inc.
Headquarters: La Jolla, CA, United States of America
Website: N/A
Year Founded: 2008
Status: Acquired
BioCentury | Jun 11, 2024
Product Development
Clinical Report: Shionogi mulls next steps after underwhelming obesity readout
Plus: Bluejay, Vir give HDV updates; Skye’s miss in glaucoma; and more
BioCentury | Apr 12, 2024
Finance
Public equity report: Acrivon refreshes balance sheet with $130M PIPE
Plus Eliem, Century raise private placements as they make acquisitions; Nurix’s AACR readout precedes follow-on; Skye uplists
BioCentury | Oct 5, 2023
Management Tracks
Jonsson to succeed Mason as head of Lilly Diabetes and Obesity
Plus: Grabulovski takes over as CEO of Araris and updates from IGM, Odyssey, Alpine, Nuvig, Rome, Saghmos, Nature’s Toolbox and Myricx
BioCentury | Aug 22, 2023
Deals
Why 5AM and Versant forged a deal to unite two cannabinoid companies
With interest in CB1 on the rise, the longtime backers of Bird Rock saw a path forward by joining its asset with Skye’s
BioCentury | Aug 22, 2023
Regulation
Aug. 21 Quick Takes: Pfizer’s Abrysvo granted maternal indication
Plus: Andreessen Horowitz co-leads $200M round for AI company Genesis, Leqembi closes in on Japan approval and more
BioCentury | Jan 20, 2022
Management Tracks
GSK’s Thirsk joins Bavarian Nordic as COO
Plus Baroldi, Bastings join Ionis, and updates from Exscientia,
Items per page:
1 - 10 of 11